FR2935001B1 - Emulsion fluorescente - Google Patents

Emulsion fluorescente

Info

Publication number
FR2935001B1
FR2935001B1 FR0804601A FR0804601A FR2935001B1 FR 2935001 B1 FR2935001 B1 FR 2935001B1 FR 0804601 A FR0804601 A FR 0804601A FR 0804601 A FR0804601 A FR 0804601A FR 2935001 B1 FR2935001 B1 FR 2935001B1
Authority
FR
France
Prior art keywords
oil phase
lambda
droplets
label
fluorescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0804601A
Other languages
English (en)
Other versions
FR2935001A1 (fr
Inventor
Laurent Guyon
Mathieu Goutayer
Y Garcia Fabrice Navarro
Nogues Isabelle Texier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0804601A priority Critical patent/FR2935001B1/fr
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to EP09786223A priority patent/EP2331144A1/fr
Priority to JP2011522565A priority patent/JP2011530577A/ja
Priority to US13/058,984 priority patent/US20110195029A1/en
Priority to CN200980139595.6A priority patent/CN102170913A/zh
Priority to CA2733994A priority patent/CA2733994A1/fr
Priority to PCT/IB2009/006766 priority patent/WO2010018460A1/fr
Publication of FR2935001A1 publication Critical patent/FR2935001A1/fr
Application granted granted Critical
Publication of FR2935001B1 publication Critical patent/FR2935001B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0078—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion microemulsion, nanoemulsion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
FR0804601A 2008-08-14 2008-08-14 Emulsion fluorescente Expired - Fee Related FR2935001B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0804601A FR2935001B1 (fr) 2008-08-14 2008-08-14 Emulsion fluorescente
JP2011522565A JP2011530577A (ja) 2008-08-14 2009-08-11 蛍光エマルジョン
US13/058,984 US20110195029A1 (en) 2008-08-14 2009-08-11 Fluorescent emulsion
CN200980139595.6A CN102170913A (zh) 2008-08-14 2009-08-11 荧光乳液
EP09786223A EP2331144A1 (fr) 2008-08-14 2009-08-11 Émulsion fluorescente
CA2733994A CA2733994A1 (fr) 2008-08-14 2009-08-11 Emulsion fluorescente
PCT/IB2009/006766 WO2010018460A1 (fr) 2008-08-14 2009-08-11 Émulsion fluorescente

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804601A FR2935001B1 (fr) 2008-08-14 2008-08-14 Emulsion fluorescente

Publications (2)

Publication Number Publication Date
FR2935001A1 FR2935001A1 (fr) 2010-02-19
FR2935001B1 true FR2935001B1 (fr) 2011-12-30

Family

ID=40220167

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0804601A Expired - Fee Related FR2935001B1 (fr) 2008-08-14 2008-08-14 Emulsion fluorescente

Country Status (7)

Country Link
US (1) US20110195029A1 (fr)
EP (1) EP2331144A1 (fr)
JP (1) JP2011530577A (fr)
CN (1) CN102170913A (fr)
CA (1) CA2733994A1 (fr)
FR (1) FR2935001B1 (fr)
WO (1) WO2010018460A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
US20140356293A1 (en) * 2012-01-20 2014-12-04 The Research Foundation of the State of University of New York Fluorescent compositions with enhanced fluorescence and methods based thereon
FR2991196B1 (fr) 2012-05-29 2014-06-27 Capsum Nanoparticules ciblantes pour une application biologique
CN104152138A (zh) * 2014-06-26 2014-11-19 苏州科技学院 一种弱光频率上转换o/w型微乳液体系
CN109187450B (zh) * 2018-08-01 2020-10-27 傅英 一种基于量子点的生物分子浓度检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906100A (en) * 1988-05-13 1990-03-06 University Of Cincinnati Method of detecting adriamycin (doxorubicin) or daunomycin in the environment
GB2251381B (en) * 1990-07-19 1995-01-25 Charwell Pharma Emulsified fluorescein diester diagnostic compositions
US6540981B2 (en) * 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
ATE257014T1 (de) * 1997-04-29 2004-01-15 Amersham Health As Lichtbilderzeugungskontrastmitteln
US6123923A (en) * 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
TW537894B (en) * 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
JP2007501797A (ja) * 2003-08-08 2007-02-01 バーンズ−ジューイッシュ ホスピタル 造影及び治療用エマルジョン粒子並びにその使用方法
EP1563851A1 (fr) * 2004-02-17 2005-08-17 Yissum Research Development Company of the Hebrew University of Jerusalem Emulsions cationiques ciblées avec des anticorps pour la livraison de drogues
US20050255044A1 (en) * 2004-05-14 2005-11-17 Lomnes Stephen J Contrast agent for combined modality imaging and methods and systems thereof
US20070148194A1 (en) * 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations
WO2008102065A1 (fr) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Emulsions fluorescentes pour l'imagerie optique
JP2010083860A (ja) * 2008-02-29 2010-04-15 Kyoto Univ ポリマーナノ微粒子及び光分子イメージング用造影剤

Also Published As

Publication number Publication date
CN102170913A (zh) 2011-08-31
JP2011530577A (ja) 2011-12-22
US20110195029A1 (en) 2011-08-11
FR2935001A1 (fr) 2010-02-19
EP2331144A1 (fr) 2011-06-15
CA2733994A1 (fr) 2010-02-18
WO2010018460A1 (fr) 2010-02-18

Similar Documents

Publication Publication Date Title
FR2935001B1 (fr) Emulsion fluorescente
Dixit et al. Microtubule plus-end tracking by CLIP-170 requires EB1
CY1124094T1 (el) Διαδικασια για την παρασκευη νανογαλακτωματων υδατος-σε-ελαιο και ελαιου-σε-υδωρ
Medintz et al. Reversible modulation of quantum dot photoluminescence using a protein-bound photochromic fluorescence resonance energy transfer acceptor
Low-Nam et al. ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding
Klotzsch et al. A critical survey of methods to detect plasma membrane rafts
Yang et al. Versatile application of fluorescent quantum dot labels in super-resolution fluorescence microscopy
JP2008524584A5 (fr)
ECSP099524A (es) Mousse
AR050946A1 (es) Composiciones para el tratamiento de la ropa.
BRPI0908299A2 (pt) "módulo de luz, sistema de iluminação e método de incorporação de dados na luz emitida por um módulo de luz de um sistema de iluminação."
UY30902A1 (es) Composiciones para bebidas comprendiendo polilisina y por lo menos un acido debil
MX2010002340A (es) Formulacion en emulsion estable que dificulta la interaccion a traves de la interfase agua-aceite.
Hevekerl et al. Forster resonance energy transfer beyond 10 nm: exploiting the triplet state kinetics of organic fluorophores
MA38560B1 (fr) Procédé de fourniture d'une caractéristique de sécurité à un document de sécurité, et document de sécurité
Klymchenko Fluorescent probes for lipid membranes: From the cell surface to organelles
Keller et al. 3‐dimensional tracking of non‐blinking ‘giant’quantum dots in live cells
Chatterjee et al. Investigating the distance limit of a metal nanoparticle based spectroscopic ruler
ES2523397B1 (es) Composición de tinta para impresión por inyección
DE502008000043D1 (de) Farbstoff-Emulsion und Emulgatorzusammensetzung sowie deren Verwendung
NO20083929L (no) Fast produkt omfattende sma oljedraper
Li et al. Photoswitchable nanoprobes offer unlimited brightness in frequency-domain imaging
Storti et al. Unveiling TRPV1 spatio-temporal organization in live cell membranes
VanDelinder et al. Mechanical splitting of microtubules into protofilament bundles by surface-bound kinesin-1
Gorshkov et al. Fluorescent quantum dots enable SARS-CoV-2 antiviral drug discovery and development

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20180430